Rare-Disease-Patient

Using ML and AI to Infer HCP Specialties for Rare Diseases

Pharmaceutical sales operations teams often rely on outdated or inaccurate data when prioritizing HCP targets, limiting promotional effectiveness. Utilizing Machine Learning and Artificial Intelligence to Infer HCP Specialities is filled with proven methodologies, specific use cases and diverse success stories on how machine learning and artificial intelligence, in conjunction with real world data, can reveal which any HCP behaves like a defined specialty.

 

Using ML and AI to Infer HCP Specialities for Rare Disease

Request a Copy